Lupus
50
14
15
19
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.0%
4 terminated out of 50 trials
82.6%
-4.0% vs benchmark
2%
1 trials in Phase 3/4
21%
4 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 19 completed trials
Clinical Trials (50)
Patient-Centered Assessment of Symptoms and Outcomes
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
Pain-Sleep in Rheumatic Disease
Exploring Biological Mechanisms Underlying the TEACH Intervention for Adolescents With Lupus
Inflammatory Disease Biobank for Immunophenotyping and Cardiovascular Research
Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
The BRIDGE Pain Study
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
JBT-101 in Systemic Lupus Erythematosus (SLE)
Direct to Patient Minimal Risk Biospecimen and Data Collection Research
Deployment o the Multidisciplinary Prospective Cohort Imminent
Complete Cognitive Intervention for cSLE
Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders
Cardiac Imaging in Systemic Disorders: the ORACLES Registry
The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research